1. Home
  2. BGIN vs TECX Comparison

BGIN vs TECX Comparison

Compare BGIN & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BGIN

Bgin Blockchain Limited Class A Ordinary Shares

N/A

Current Price

$2.55

Market Cap

332.6M

Sector

N/A

ML Signal

N/A

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

N/A

Current Price

$33.31

Market Cap

393.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
BGIN
TECX
Founded
2019
2019
Country
Singapore
United States
Employees
N/A
51
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
332.6M
393.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BGIN
TECX
Price
$2.55
$33.31
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$80.40
AVG Volume (30 Days)
4.2K
552.9K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.38
$13.70
52 Week High
$5.19
$35.99

Technical Indicators

Market Signals
Indicator
BGIN
TECX
Relative Strength Index (RSI) 39.42 72.82
Support Level $2.43 $16.83
Resistance Level $2.99 N/A
Average True Range (ATR) 0.13 2.45
MACD -0.01 1.23
Stochastic Oscillator 15.15 82.62

Price Performance

Historical Comparison
BGIN
TECX

About BGIN Bgin Blockchain Limited Class A Ordinary Shares

BGIN Blockchain Ltd is operating through its subsidiaries and is engaged in digital asset technology company based in Singapore, Hong Kong and the U.S. with proprietary cryptocurrency-mining technologies and a strategic focus on alternative cryptocurrencies. It design and sell mining machines equipped with proprietary 8nm or 12nm ASIC chips under different series dedicated to the mining of KAS coins, ALPH coins, and RXD coins. The Company operated in two reportable segments, which were the cryptocurrency mining and the sale of mining machines Key revenue is generated from Sale of mining machines. Geographically, It derives key revenue from Hong Kong, China and Vietnam, United States, Singapore, etc.

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

Share on Social Networks: